Abstract:Jian Tang, 1 Hong Yuan, 2 Yun Long Wu, 1 Shui Fu, 3 Xiao Yong Pan 4 1 Department of Intensive Care, First People's Hospital of Linping District, Hangzhou, Zhejiang Province, People's Republic of China; 2 Department of Cardiology, First People's Hospital of Linping District, Hangzhou, Zhejiang Province, People's Republic of China; 3 Clinical Laboratory Department, First People's Hospital of Linping District, Hangzhou, Zhejiang Province, People's Republic of China; 4 Clinical Laboratory Department, The People's Hospital of Cangnan Zhejiang, Wenzhou, Zhejiang Province, People's Republic of China Correspondence: Xiao Yong Pan, Clinical Laboratory Department, The People's Hospital of Cangnan Zhejiang, Wenzhou, Zhejiang Province, People's Republic of China, Email Objective: To explore the serial measurement of heparin-binding protein and D-dimer in the prediction of 28-day mortality and efficacy evaluation of critically-ill patients with sepsis. Methods: We recruited a total of 51 patients with sepsis in the ICU of our hospital. They were divided into a survival group or a death group according to their prognosis 28 days after treatment. The HBP and D-dimer levels in these patients were determined on the 1st (24h), 3rd, and 5th days. Besides, the sequential organ failure assessment (SOFA) score of these patients was recorded at admission. The patients in both groups were subjected to comparison regarding HBP and D-dimer levels and SOFA scores within 24h of admission. Additionally, a correlation between the levels of HBP and D-dimer and the SOFA score was statistically measured, while the predictive effectiveness of these factors for the prognosis of patients with sepsis was also determined. Moreover, the dynamic changes in HBP and D-dimer during the treatment of both groups were analyzed. Results: The HBP and D-dimer levels and the SOFA scores in the survival group were considerably lower than those in the death group, and the differences were statistically significant ( P < 0.05). Additionally, the levels of HBP and D-dimer in sepsis patients were positively correlated with the SOFA score ( P < 0.05). The area under the curve (AUC) of HBP, D-dimer, and their combination in predicting the prognosis of patients with sepsis was 0.824, 0.771, and 0.830, respectively. Besides, the sensitivity and specificity of their combination in predicting the prognosis of patients with sepsis were 68.42% and 92.31%, respectively. The HBP and D-dimer levels presented a downward trend in the survival group during treatment, while they exhibited an upward trend in the death group. Conclusion: HBP and D-dimer realize high predictive effectiveness for the prognosis of patients with sepsis, while the combined use of these two factors achieves superior effectiveness. Thus, they can be applied to the prediction of 28-day mortality and efficacy evaluation of sepsis patients. Keywords: sepsis, heparin-binding protein, HBP, D-dimer, sequential organ failure assessment score, SOFA, prognosis Sepsis is an inflammatory response syndrome that is caused by numerous infectious factors and mediated by various inflammatory reaction substances. The disease is a life-threatening organ dysfunction caused by maladjustment of the host's immune response to infection. 1,2 It affects millions of people all over the world every year, accounting for between one-sixth and one-third of all deaths. Cases of sepsis have witnessed increasing incidence in recent years, 3 and it has become a global burden in critical medicine. Patients with sepsis usually present rapid progression and it is difficult to achieve favorable outcomes. Therefore, early diagnosis, efficacy monitoring, and prognosis assessment are of great clinical significance for the prevention of sepsis. 4 Biomarkers have been used to assist with the diagnosis of sepsis as well as determining the severity of the disease. 5 In the past decade, researchers have verified that conventional cell blood count (CBC) parameters are effective biomarkers for the screening of septicemia. 6 Besides, emerging biological markers such as pentraxin-3 (PTX3), 7 clusterin, 8 IL-18, 9 and circRNA-miRNA-lncRNA networks 10 can also be used to obtain prognostic information on patients with sepsis, thereby providing guidance and monitoring for relevant treatment. Heparin-binding protein (HBP) is a novel biomarker related to infectious diseases. As an acute phase protein (APP), HBP can be used to effectively assess the severity of sepsis. Besides, it is more crucial in the early diagnosis and efficacy monitoring of patients with septic shock.<s -Abstract Truncated-

Heparin-binding protein as a predictive and diagnostic biomarker for severe sepsis and septic shock in patients with sepsis

Heparin-binding Protein As a Biomarker of Severe Sepsis in the Pediatric Intensive Care Unit: A Multicenter, Prospective Study

Elevated plasma levels of heparin-binding protein in intensive care unit patients with severe sepsis and septic shock

Diagnostic and prognostic value of heparin-binding protein in sepsis: A systematic review and meta-analysis

Usefulness of the heparin-binding protein level to diagnose sepsis and septic shock according to Sepsis-3 compared with procalcitonin and C reactive protein: a prospective cohort study in China

The Predictive Value of Heparin-Binding Protein and D-Dimer in Patients with Sepsis

Heparin-binding protein as a biomarker for the diagnosis of sepsis in the intensive care unit: a retrospective cross-sectional study in China

Dynamic changes in heparin-binding protein as a prognostic biomarker for 30-day mortality in sepsis patients in the intensive care unit

Heparin-binding protein (HBP) improves prediction of sepsis-related acute kidney injury

A Promising Candidate: Heparin-Binding Protein Steps onto the Stage of Sepsis Prediction

The performance of a combination of heparin-binding protein with other biomarkers for sepsis diagnosis: an observational cohort study

Comparison of the clinical value of plasma heparin-binding protein, procalcitonin and C-reactive protein in the early diagnosis of sepsis

Heparin‐binding protein: a key player in the pathophysiology of organ dysfunction in sepsis

Heparin binding protein in severe COVID-19—A prospective observational cohort study

Heparin-binding protein-enhanced quick SOFA score improves mortality prediction in sepsis patients

Diagnostic Value of Serum Heparin Binding Protein, Blood Lactic Acid Combined with hs-CRP in Sepsis and Its Relationship with Prognosis

Integration of heparin-binding protein and interleukin-6 in the early prediction of respiratory failure and mortality in pneumonia by SARS-CoV-2 (COVID-19)

Sepsis biomarkers in unselected patients on admission to intensive or high-dependency care

Heparin-binding protein is important for vascular leak in sepsis

Heparin-Binding Protein: A Prognostic Biomarker Associated with Severe or Complicated Community-Acquired Pneumonia in Children

Heparin-binding protein as a biomarker of gastrointestinal dysfunction in critically ill patients: a retrospective cross-sectional study in China